Noticias de TEM

Mercado

Noticias del mercado

Últimas noticias sobre TEM — 794 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: TEM ✕ 794 resultados
07/09/2026 TEM_US — Kalkine Media
Tempus AI (NASDAQ:TEM): Can Growth Outrun Rate Risks?

Tempus AI (NASDAQ:TEM) is in focus as growth stocks prepare for the next U.S. session after the Labor Day market closure.

07/09/2026 TEM_US — Seeking Alpha
Cathie Wood's weekly recap: loads Rocket Lab, Block; cuts Palantir, Tempus AI (ARKK:BATS)

Cathie Wood’s Ark Invest reshuffles: big buys in Rocket Lab and Block, sells Tempus AI, Palantir and Shopify.

07/09/2026 TEM_US — MarketBeat
Tempus AI, Inc. $TEM Shares Acquired by Washington Trust Advisors Inc.

Washington Trust Advisors Inc. increased its stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 49.1% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 89,166 shares of the company

07/09/2026 TEM_US — MarketBeat
Public Employees Retirement System of Ohio Makes New $1.77 Million Investment in Tempus AI, Inc. $TEM

Public Employees Retirement System of Ohio acquired a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 30,639 shares of the company

06/09/2026 TEM_US — MarketBeat
Wellington Management Group LLP Sells 123,748 Shares of Tempus AI, Inc. $TEM

Wellington Management Group LLP reduced its position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 24.1% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 390,241 shares of the company

05/09/2026 TEM_US — finance.biggo.com
Personalized Cancer Vaccine Breakthrough Ignites Sequencing Sector, Tempus AI's Personalis Bid Faces Rivalry Speculation

Moderna and Merck's personalized mRNA cancer vaccine mRNA-4157 achieved a breakthrough in Phase 3 trials, triggering a sharp rally in oncology…

Página 10 de 40